Trastuzumab for HER2-positive breast cancer: a systematic review

A systematic review of the best available evidence on the use of trastuzumab (Herceptin®) in breast cancer.

File name: hrsrw-trastuzumab-for-her2-...df
File size: 539.3 KB
Cancer Type: Breast cancer
Publication Audience: Resources for health professionals
Year: 2007
Document Status: Research and data reports

This resource is 5 years or older. It includes data or research findings at an earlier point in time and is available to the public for research and reference purposes.

Download PDF

Return to search results